Animal research used weight-based dosing roughly in the range of 10 mcg per kg, which for a 80 kg human would be approximately 800 mcg per day, though extrapolation from rodent to human dose is not straightforward and this is not a clinical recommendation
Conditions persisting six months or longer have established dysfunctional tissue patterns that take longer to remodel
70% of customers report seeing and feeling benefits within 16 weeks, including deeper sleep, calmer mood, improved energy, and overall improved health.*
FOXO4-DRI (also known as Proxofim) is a synthetic D-retro-inverso peptide designed to selectively induce apoptosis in senescent cells by disrupting the FOXO4p53 protein interaction [1] [2]
It was developed from angiotensin IV by the Harding group, which was studying angiotensin IVs cognitive effects
It addresses both the caloric intake side and the metabolic health side of the obesity equation simultaneously